Akkaif, M. A., Daud, N. A. A., Noor, D. A. M., Sha’aban, A., Kader, M. A. S. A., & Ibrahim, B. (2025). The Impact of CYP2C19 Genotype on the Platelet Reactivity Index (PRI) among Chronic Coronary Syndromes (CCS) Patients Undergoing Percutaneous Coronary Intervention (PCI). Cardiovascular Drugs and Therapy, 39(2), 347-356. https://doi.org/10.1007/s10557-024-07544-6
Chicago-referens (17:e uppl.)Akkaif, Mohammed Ahmed, Nur Aizati Athirah Daud, Dzul Azri Mohamed Noor, Abubakar Sha’aban, Muhamad Ali SK Abdul Kader, och Baharudin Ibrahim. "The Impact of CYP2C19 Genotype on the Platelet Reactivity Index (PRI) Among Chronic Coronary Syndromes (CCS) Patients Undergoing Percutaneous Coronary Intervention (PCI)." Cardiovascular Drugs and Therapy 39, no. 2 (2025): 347-356. https://doi.org/10.1007/s10557-024-07544-6.
MLA-referens (9:e uppl.)Akkaif, Mohammed Ahmed, et al. "The Impact of CYP2C19 Genotype on the Platelet Reactivity Index (PRI) Among Chronic Coronary Syndromes (CCS) Patients Undergoing Percutaneous Coronary Intervention (PCI)." Cardiovascular Drugs and Therapy, vol. 39, no. 2, 2025, pp. 347-356, https://doi.org/10.1007/s10557-024-07544-6.
